Merck Decides Not to Pursue Evofosfamide Further in Soft Tissue Sarcoma and Pancreatic Cancer
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK-based media - Despite signs of activity in locally advanced and metastatic pancreatic cancer, two Phase III studies did not meet pre-specified primary endpoints - Merck will focus efforts on more promising candidates in pipeline Merck, a leading science and ...